| 000 | 01544 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250517084717.0 | ||
| 264 | 0 | _c20171205 | |
| 008 | 201712s 0 0 eng d | ||
| 022 | _a0065-2598 | ||
| 024 | 7 |
_a10.1007/5584_2016_220 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMatakova, T | |
| 245 | 0 | 0 |
_aAssociations of CYP1A2 Polymorphisms with the Risk Haplotypes in Lung Cancer in the Slovak Population. _h[electronic resource] |
| 260 |
_bAdvances in experimental medicine and biology _c2016 |
||
| 300 |
_a23-32 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 |
_aCytochrome P-450 CYP1A2 _xgenetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aGenetic Predisposition to Disease |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 |
_aHaplotypes _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung Neoplasms _xgenetics |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 |
_aPolymorphism, Single Nucleotide _xgenetics |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRisk Factors |
| 700 | 1 | _aHalasova, E | |
| 700 | 1 | _aDzian, A | |
| 700 | 1 | _aHruby, R | |
| 700 | 1 | _aHalasa, M | |
| 700 | 1 | _aJavorka, K | |
| 700 | 1 | _aSkerenova, M | |
| 773 | 0 |
_tAdvances in experimental medicine and biology _gvol. 911 _gp. 23-32 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/5584_2016_220 _zAvailable from publisher's website |
| 999 |
_c25837397 _d25837397 |
||